Research output per year
Research output per year
- 1 - 50 out of 126 results
Search results
-
2024
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
Kitagawa, Y., Matsuda, S., Gotoda, T., Kato, K., Wijnhoven, B., Lordick, F., Bhandari, P., Kawakubo, H., Kodera, Y., Terashima, M., Muro, K., Takeuchi, H., Mansfield, P. F., Kurokawa, Y., So, J., Mönig, S. P., Shitara, K., Rha, S. Y., Janjigian, Y. & Takahari, D. & 43 others, , May 2024, In: Gastric Cancer. 27, 3, p. 401-425 25 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023
Ekmekciu, I., Nieto, A. E., Scheck, M. K., Heise, C., Mavroeidi, I. A., Kunzmann, V., Götze, T. O., Wege, H., Reinacher-Schick, A., Lorenzen, S., Hofheinz, R. D. & Sommerhäuser, G., 1 Mar 2024, In: Oncology Research and Treatment. 47, 5, p. 229-232 4 p.Research output: Contribution to journal › Letter › peer-review
-
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy
Masetti, M., Al-Batran, S. E., Goetze, T. O., Thuss-Patience, P., Knorrenschild, J. R., Goekkurt, E., Folprecht, G., Ettrich, T. J., Lindig, U., Luley, K. B., Pink, D., Dechow, T., Sookthai, D., Junge, S., Loose, M., Pauligk, C. & Lorenzen, S., 15 Jun 2024, In: International Journal of Cancer. 154, 12, p. 2142-2150 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023
Scheck, M. K., Ekmekciu, I., Sommerhäuser, G., Heise, C., Mavroeidi, I. A., Kunzmann, V., Wege, H., Reinacher-Schick, A., Hofheinz, R. D., Oliver Götze, T., Lorenzen, S. & Nieto, A. E., 13 Mar 2024, In: Oncology Research and Treatment. 47, 5, p. 224-228 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Lordick, F., Al-Batran, S. E., Arnold, D., Borner, M., Bruns, C. J., Eisterer, W., Faber, G., Gockel, I., Köberle, D., Lorenzen, S., Möhler, M., Pritzkuleit, R., Stahl, M., Thuss-Patience, P., Wöll, E., Zander, T. & Maschmeyer, G., Jan 2024, In: Gastric Cancer. 27, 1, p. 6-18 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments
Scheck, M. K., Hofheinz, R. D. & Lorenzen, S., Apr 2024, In: Cancers. 16, 7, 1336.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
the LEAP-017 Investigators, 20 Aug 2024, In: Journal of Clinical Oncology. 42, 24, p. 2918-2927 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Medikamentöse Therapiestrategien des Magenkarzinoms
Translated title of the contribution :Drug therapy strategies for gastric cancer Research output: Contribution to journal › Article › peer-review
-
Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment: An expert view
Gascón, P., Awada, A., Karihtala, P., Lorenzen, S. & Minichsdorfer, C., Jun 2024, In: Wiener Klinische Wochenschrift. 136, 11-12, p. 362-368 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023
Heise, C., Nieto, A. E., Scheck, M. K., Ekmekciu, I., Sommerhäuser, G., Reinacher-Schick, A., Hofheinz, R. D., Lorenzen, S., Wege, H., Kunzmann, V., Götze, T. O. & Mavroeidi, I. A., 22 Feb 2024, In: Oncology Research and Treatment. 47, 5, p. 233-237 5 p.Research output: Contribution to journal › Letter › peer-review
-
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
AIO and SAKK Study Working Groups, 1 Feb 2024, In: Journal of Clinical Oncology. 42, 4, p. 410-420 11 p.Research output: Contribution to journal › Article › peer-review
28 Scopus citations -
Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option
Park, H., Klempner, S. J., Chao, J., Wainberg, Z. A., Lukanowski, M., Chenji, S., Bourke, S., Chatterjee, A. & Lorenzen, S., 2024, In: Frontiers in Oncology. 14, 1419338.Research output: Contribution to journal › Review article › peer-review
Open Access -
Standardisierte und qualitätsgesicherte prädiktive PD-L1-Testung im oberen Gastrointestinaltrakt
Translated title of the contribution :Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract. German version Research output: Contribution to journal › Article › peer-review
Open Access -
Therapie des Magenkarzinoms und AEG – wie reihen sich klinische AIO-Studien in die Therapielandschaft ein?
Translated title of the contribution :Treatment of gastric cancer and adenocarcinoma of the GEJ—how do AIO clinical studies fit into the treatment landscape? Research output: Contribution to journal › Article › peer-review
-
Was ist neu beim Magenkarzinom?
Translated title of the contribution :What's new in gastric cancer? Research output: Contribution to journal › Review article › peer-review
-
2023
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma
Porth, I., Hirsch, D., Ceribas, Y., Weidner, P., Weichert, W., Götze, T. O., Perner, S., Luley, K., Heyer, C. M., de la Torre, C., Hofheinz, R. D., Lorenzen, S. & Gaiser, T., Apr 2023, In: European Journal of Cancer. 183, p. 119-130 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Early clinical trial unit tumor board: a real-world experience in a national cancer network
Weiss, L., Dorman, K., Boukovala, M., Schwinghammer, F., Jordan, P., Fey, T., Hasselmann, K., Subklewe, M., Bücklein, V., Bargou, R., Goebeler, M., Sayehli, C., Spoerl, S., Lüke, F., Heudobler, D., Claus, R., von Luettichau, I., Lorenzen, S., Lange, S. & Westphalen, C. B. & 3 others, , Nov 2023, In: Journal of Cancer Research and Clinical Oncology. 149, 14, p. 13383-13390 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research
Hofheinz, R., Lorenzen, S. & Bohlmann, M. K., Jul 2023, In: Cancers. 15, 13, 3333.Research output: Contribution to journal › Editorial
Open Access -
Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning
Hörst, F., Ting, S., Liffers, S. T., Pomykala, K. L., Steiger, K., Albertsmeier, M., Angele, M. K., Lorenzen, S., Quante, M., Weichert, W., Egger, J., Siveke, J. T. & Kleesiek, J., 1 Aug 2023, In: JCO Clinical Cancer Informatics. 7, p. e2300038Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Medikamentöse Therapie des fortgeschrittenen/metastasierten Magenkarzinoms
Translated title of the contribution :Drug treatment for advanced/metastatic gastric cancer Research output: Contribution to journal › Article › peer-review
-
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients
Hiltner, T., Kohlruss, M., Herz, A. L., Lorenzen, S., Novotny, A., Hapfelmeier, A., Jesinghaus, M., Slotta-Huspenina, J., Sisic, L., Gaida, M. M., Weichert, W., Ott, K. & Keller, G., Aug 2023, In: Journal of Cancer Research and Clinical Oncology. 149, 10, p. 7651-7662 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Neoadjuvant and adjuvant approaches in gastroesophageal cancers
Scheck, M. K., Masetti, M. & Lorenzen, S., 1 Jul 2023, In: Current Opinion in Oncology. 35, 4, p. 318-325 8 p.Research output: Contribution to journal › Review article › peer-review
-
Oncology in Europe
Lordick, F., Lorenzen, S. & Hofheinz, R., 1 Sep 2023, In: Oncology Research and Treatment. 46, 9, p. 345-347 3 p.Research output: Contribution to journal › Editorial
Open Access -
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)
Tintelnot, J., Stein, A., Al-Batran, S. E., Ettrich, T., Götze, T., Grün, B., Haag, G. M., Heuer, V., Hofheinz, R. D., Homann, N., Bröring, T. S., Cruz, M. S., Kurreck, A., Lorenzen, S., Moosmann, N., Müller, C., Schuler, M., Siegler, G., Binder, M. & Gökkurt, E., 2023, In: Frontiers in Oncology. 13, 1272175.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy
Goetze, T. O., Stein, A., Lorenzen, S., Habibzada, T., Goekkurt, E., Herhaus, P., Loose, M., Sookthai, D., Brulin, T., Ihrig, K., Pauligk, C. & Al-Batran, S. E., 15 Nov 2023, In: International Journal of Cancer. 153, 10, p. 1726-1733 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
Lorenzen, S., Schwarz, A., Pauligk, C., Goekkurt, E., Stocker, G., Knorrenschild, J. R., Illerhaus, G., Dechow, T., Moehler, M., Moulin, J. C., Pink, D., Stahl, M., Schaaf, M., Goetze, T. O. & Al-Batran, S. E., Dec 2023, In: BMC Cancer. 23, 1, 561.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial
Stocker, G., Lorenzen, S., Ettrich, T., Herz, A. L., Longo, F., Kiani, A., Venerito, M., Trojan, J., Mahlberg, R., Moosmann, N., Chibaudel, B., Kubicka, S., Greil, R., Daum, S., Geissler, M., Larcher-Senn, J., Keller, G., Lordick, F. & Haag, G. M., Jun 2023, In: ESMO Open. 8, 3, 101572.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ösophagus Version 3.1 – Juni 2022 – AWMF-Registernummer: 021/023OL
Translated title of the contribution :S3 guideline on the diagnosis and treatment of squamous cell carcinomas and adenocarcinomas of the esophagus: Version 3.1 - June 2022 - Association of the Scientific Medical Societies in Germany (AWMF) registry number: 021/023OL Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ösophagus Version 3.1 – Juni 2022 – AWMF-Registernummer: 021/023OL
Translated title of the contribution :S3 guideline on the diagnosis and treatment of squamous cell carcinomas and adenocarcinomas of the esophagus: Version 3.1 - June 2022 - Association of the Scientific Medical Societies in Germany (AWMF) registry number: 021/023OL Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract
The Interdisciplinary Expert Group, Nov 2023, In: Journal of Cancer Research and Clinical Oncology. 149, 17, p. 16231-16238 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
2022
Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
Petrillo, A., Lorenzen, S. & van Laarhoven, H. W. M., Dec 2022, In: ESMO Open. 7, 6, 100613.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Efficacy of Ipilimumab vs FOLFOX in Combination with Nivolumab and Trastuzumab in Patients with Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial
Stein, A., Paschold, L., Tintelnot, J., Goekkurt, E., Henkes, S. S., Simnica, D., Schultheiss, C., Willscher, E., Bauer, M., Wickenhauser, C., Thuss-Patience, P., Lorenzen, S., Ettrich, T., Riera-Knorrenschild, J., Jacobasch, L., Kretzschmar, A., Kubicka, S., Al-Batran, S. E., Reinacher-Schick, A. & Pink, D. & 6 others, , Aug 2022, In: JAMA Oncology. 8, 8, p. 1150-1158 9 p.Research output: Contribution to journal › Article › peer-review
Open Access39 Scopus citations -
European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions
Pavlakis, N., Tincknell, G., Lim, L. E., Muro, K., Obermannova, R., Lorenzen, S., Chua, Y. J., Jackson, C., Karapetis, C. S., Price, T., Chantrill, L., Segelov, E. & Lordick, F., 2022, In: Therapeutic Advances in Medical Oncology. 14Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel – results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO
Lorenzen, S., Thuss-Patience, P., Pauligk, C., Gökkurt, E., Ettrich, T., Lordick, F., Stahl, M., Reichardt, P., Sökler, M., Pink, D., Probst, S., Hinke, A., Goetze, T. O. & Al-Batran, S. E., Apr 2022, In: European Journal of Cancer. 165, p. 48-57 10 p.Research output: Contribution to journal › Article › peer-review
19 Scopus citations -
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314)
Modest, D. P., Karthaus, M., Kasper, S., Moosmann, N., Keitel, V., Kiani, A., Uhlig, J., Jacobasch, L., Fischer v. Weikersthal, L., Fuchs, M., Kaiser, F., Lerchenmüller, C., Sent, D., Junghanß, C., Held, S., Lorenzen, S., Kaczirek, K., Jung, A., Stintzing, S. & Heinemann, V., Sep 2022, In: European Journal of Cancer. 173, p. 297-306 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Nachwuchsaktivität der Jungen Onkologie
Translated title of the contribution :Fostering junior faculty in oncology Research output: Contribution to journal › Review article › peer-review
-
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation
Schenck, K., Masetti, M., Pfarr, N. & Lorenzen, S., 1 Apr 2022, In: Oncology Research and Treatment. 45, 4, p. 222-226 5 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK)
Lorenzen, S., Quante, M., Rauscher, I., Slotta-Huspenina, J., Weichert, W., Feith, M., Friess, H., Combs, S. E., Weber, W. A., Haller, B., Angele, M., Albertsmeier, M., Blankenstein, C., Kasper, S., Schmid, R. M., Bassermann, F., Schwaiger, M., Liffers, S. T. & Siveke, J. T., Nov 2022, In: European Journal of Cancer. 175, p. 99-106 8 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma
Masetti, M., Lindinger, M. & Lorenzen, S., 1 Jun 2022, In: Oncology Research and Treatment. 45, 6, p. 375-379 5 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL
Kumbrink, J., Bohlmann, L., Mamlouk, S., Redmer, T., Peilstöcker, D., Li, P., Lorenzen, S., Algül, H., Kasper, S., Hempel, D., Kaiser, F., Michl, M., Bartsch, H., Neumann, J., Klauschen, F., von Bergwelt-Baildon, M., Modest, D. P., Stahler, A., Stintzing, S. & Jung, A. & 4 others, , Aug 2022, In: Cancers. 14, 15, 3631.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Studien der Arbeitsgruppe Magen-Ösophagus-Tumoren der Arbeitsgemeinschaft Internistische Onkologie (AIO)
Translated title of the contribution :Studies of the oesophageal and gastric cancer working group of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Research output: Contribution to journal › Review article › peer-review
-
Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
Tintelnot, J., Ristow, I., Sauer, M., Simnica, D., Schultheiß, C., Scholz, R., Goekkurt, E., von Wenserski, L., Willscher, E., Paschold, L., Lorenzen, S., Riera-Knorrenschild, J., Depenbusch, R., Ettrich, T. J., Dörfel, S., Al-Batran, S. E., Karthaus, M., Pelzer, U., Hinke, A. & Bauer, M. & 7 others, , 20 Dec 2022, In: Frontiers in Oncology. 12, 993611.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
2021
Immuntherapie von Tumoren im oberen Gastrointestinaltrakt
Translated title of the contribution :Immunotherapy in upper gastrointestinal cancer Research output: Contribution to journal › Review article › peer-review
-
Innovative Therapieansätze bei Tumoren des Magens und des Ösophagus
Translated title of the contribution :Innovative therapeutic approaches for stomach and esophagus tumors Research output: Contribution to journal › Article › peer-review
-
Innovative Therapieansätze bei Tumoren des Magens und des Ösophagus
Translated title of the contribution :Innovative therapeutic approaches for stomach and esophagus tumors Research output: Contribution to journal › Article › peer-review
-
Moderne Konzepte der Systemtherapie zur adjuvanten und palliativen Behandlung des lokal fortgeschrittenen oder metastasierten Ösophaguskarzinoms
Translated title of the contribution :Modern concepts of systemic treatment for adjuvant and palliative treatment of locally advanced or metastasized esophageal cancer Research output: Contribution to journal › Review article › peer-review
-
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
Stein, A., Simnica, D., Schultheiß, C., Scholz, R., Tintelnot, J., Gökkurt, E., Von Wenserski, L., Willscher, E., Paschold, L., Sauer, M., Lorenzen, S., Riera-Knorrenschild, J., Depenbusch, R., Ettrich, T. J., Dörfel, S., Al-Batran, S. E., Karthaus, M., Pelzer, U., Waberer, L. & Hinke, A. & 7 others, , 27 Jul 2021, In: Journal for ImmunoTherapy of Cancer. 9, 7, e002844.Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations -
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
Götze, T. O., Piso, P., Lorenzen, S., Bankstahl, U. S., Pauligk, C., Elshafei, M., Amato, G., Reim, D., Bechstein, W. O., Königsrainer, A., Mönig, S. P., Rau, B., Schwarzbach, M. & Al-Batran, S. E., Dec 2021, In: BMC Cancer. 21, 1, 1158.Research output: Contribution to journal › Article › peer-review
Open Access26 Scopus citations -
Therapie ösophagogastraler Tumoren: Magenkarzinom
Translated title of the contribution :Treatment of esophagogastric junction cancers: gastric cancer Research output: Contribution to journal › Review article › peer-review
-
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
Tabernero, J., Shitara, K., Zaanan, A., Doi, T., Lorenzen, S., Van Cutsem, E., Fornaro, L., Catenacci, D. V. T., Fougeray, R., Moreno, S. R., Azcue, P., Arkenau, H. T., Alsina, M. & Ilson, D. H., Aug 2021, In: ESMO Open. 6, 4, 100200.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations